Device Extra Cellular Matrix

Oasis

Payments companies reported to CMS as associated with Oasis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.7Massociated payments (2023-2025)

4,629clinicians with associated payments

6companies reporting

By year

2023 $341K

2024 $774K

2025 $621K

Payments reported as associated with Oasis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Foot & Ankle Surgery $331K

Surgery $273K

Plastic Surgery $240K

Podiatrist $208K

Plastic and Reconstructive Surgery $121K

Vascular Surgery $107K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Oasis

These are the largest totals companies reported as associated with Oasis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Vineet Mehan	Falls Church, VA	Plastic Surgery	$115,558.15
Rajiv Sood	Augusta, GA	Plastic and Reconstructive Surgery	$88,707.98
Hana Lopez Quinones	Bronx, NY	Surgery	$67,863.37
Harry Schneider	Cambridge, MA	Foot & Ankle Surgery	$59,302.86
Charles Parks	San Francisco, CA	Foot & Ankle Surgery	$58,710.32
Lee Goldstein	Stratford, CT	Vascular Surgery	$54,670.55
David Zabel	Augusta, GA	Plastic Surgery	$53,368.94
Brett Chatman	Philadelphia, PA	Surgery	$51,463.93
Robert Davis	Bridgeport, CT	Podiatrist	$47,100.08
Zachary Bauman	Omaha, NE	Surgical Critical Care	$46,770.66

Prescribed Oasis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.